IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery
The company is moving towards complex and more differentiated products
It is the first presbyopia-correcting lens implant for cataract surgery
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Results from year two of the pivotal Phase 3 KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one
Subscribe To Our Newsletter & Stay Updated
